PNC Financial Services Group Inc. Has $224,000 Position in Smith & Nephew plc (NYSE:SNN)

PNC Financial Services Group Inc. boosted its holdings in Smith & Nephew plc (NYSE:SNN) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,120 shares of the medical equipment provider’s stock after buying an additional 399 shares during the period. PNC Financial Services Group Inc.’s holdings in Smith & Nephew were worth $224,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Charles Schwab Investment Management Inc. lifted its holdings in Smith & Nephew by 29.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 27,199 shares of the medical equipment provider’s stock valued at $847,000 after buying an additional 6,164 shares during the period. Stifel Financial Corp acquired a new position in Smith & Nephew in the third quarter valued at approximately $1,258,000. Maverick Capital Ltd. bought a new stake in Smith & Nephew in the third quarter valued at approximately $2,086,000. Blue Trust Inc. increased its stake in Smith & Nephew by 26.0% in the fourth quarter. Blue Trust Inc. now owns 5,871 shares of the medical equipment provider’s stock valued at $144,000 after purchasing an additional 1,213 shares in the last quarter. Finally, GAMMA Investing LLC increased its stake in Smith & Nephew by 31.8% in the fourth quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock valued at $73,000 after purchasing an additional 718 shares in the last quarter. 25.64% of the stock is currently owned by institutional investors and hedge funds.

Smith & Nephew Stock Down 1.3 %

Shares of SNN stock opened at $28.08 on Friday. The firm has a fifty day moving average of $26.77 and a 200-day moving average of $27.07. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. Smith & Nephew plc has a 12-month low of $23.65 and a 12-month high of $31.72. The company has a market capitalization of $12.27 billion, a price-to-earnings ratio of 13.00, a P/E/G ratio of 1.26 and a beta of 0.83.

Smith & Nephew Increases Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Friday, March 28th will be given a dividend of $0.447 per share. This is an increase from Smith & Nephew’s previous semi-annual dividend of $0.29. The ex-dividend date is Friday, March 28th. This represents a dividend yield of 2.5%. Smith & Nephew’s dividend payout ratio is currently 41.20%.

Analyst Ratings Changes

Several equities research analysts have commented on SNN shares. UBS Group downgraded shares of Smith & Nephew from a “buy” rating to a “neutral” rating in a research note on Wednesday, March 12th. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $27.00 target price on shares of Smith & Nephew in a research note on Monday, March 17th. Finally, StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, February 26th. Four equities research analysts have rated the stock with a hold rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Smith & Nephew presently has a consensus rating of “Hold” and an average target price of $27.00.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.